GRADUATE PROGRAM

Pharmacology

Presentation

 The Postgraduate Course in Pharmacology, linked to the Institute of Biomedical Sciences of the University of São Paulo (ICB/USP), was created in December 1977 by Ordinance GR-1507, at the Master’s level, and accredited in 1981 by the Federal Board of Education. On June 9th of that same year, the course was instituted at the Ph.D. level through Portaria GR-885 and GR-1538.

Since its creation, the Program has been to unite research in the frontier of knowledge in Pharmacology and related areas, as well as the formation of highly qualified and skilled researchers for the development of independent and innovative analysis in the various areas of the Health Sciences. 

The Postgraduate program in Pharmacology is institutionally supported by CAPES, CNPq, FAPESP, and the USP’s Research Dean’s Office (through the Research Support Centers – NAPs) in the promotion of Master’s, Ph.D., Post-Doctorate, and productivity in research scholarships, besides the financing of projects, scientific initiation, and pre-scientific initiation. The NAPs have been a very strong point of incentive to internationalization and technological innovation. 

areas of concentration

 The Graduate Program in Pharmacology is guaranteed in three areas of concentration:

Neuroscience and Behavior

 where conceptual and methodological problems are investigated in the experimental analysis of biochemistry, intracellular signaling and behavioral manifestation, related to neuro-endocrine-pharmacology and immunomodulation; neuro-inflammation, aging and neurodegenerative diseases; neurobiology of addiction to drugs of abuse; behavioral and molecular neuroscience, with an emphasis on emotional behaviors. These research projects are developed with animals and/or humans; 

Inflammation and Cancer

 where the inflammatory/hyperalgesic and cardiopulmonary activities induced by vasoactive mediators (neurogenic inflammation), pollutants and toxins are investigated; the use of laser in analgesic and anti-inflammatory therapy and the pathophysiology of pulmonary and systemic inflammation, in addition to the role of female sex hormones in these last processes; 

Cardiovascular, Cardiorespiratory and Endocrine Systems

 where the processes involved in the neural control of the cardiorespiratory system and in vascular pathophysiology and pharmacology in metabolic and cardiovascular diseases are investigated;